AMY B WECHSLER
CIK 1677300 · last filed 2026-05-26
AMY B WECHSLER is a corporate insider who has filed 55 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for BHC, was dated May 26, 2026. Across all open-market trades the lifetime net is −$350.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.59M
2
55
-$350.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BHC | Director | 313,585 | $5.06 | $1.59M | -$350.8K | 40 | 2026-05-26 |
| Damora Therapeutics, Inc. (GLTO) Delisted | Director | — | $28.69 | — | $0 | 2 | 2025-06-20 |
Recent Filings
55 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-26 | BHC | Grant (A) | +45,871 | $0 | EDGAR |
| 2026-04-02 | BHC | Grant (A) | +1,273 | $6.9K | EDGAR |
| 2026-01-02 | BHC | Grant (A) | +989 | $0 | EDGAR |
| 2025-10-02 | BHC | Grant (A) | +1,065 | $0 | EDGAR |
| 2025-07-02 | BHC | Grant (A) | +1,032 | $0 | EDGAR |
| 2025-06-20 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-05-20 | BHC | Grant (A) | +54,347 | $0 | EDGAR |
| 2025-04-01 | BHC | Grant (A) | +1,062 | $6.9K | EDGAR |
| 2025-01-02 | BHC | Grant (A) | +852 | $6.9K | EDGAR |
| 2024-10-15 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |